![Secretive Contract Manufacturing Arrangements Complicate Solutions to Shortages of Generics](https://cdn.cancerletter.com/media/2024/01/08055736/40-01-ben-venue-laboratories.jpg)
![Secretive Contract Manufacturing Arrangements Complicate Solutions to Shortages of Generics](https://cdn.cancerletter.com/media/2024/01/08055736/40-01-ben-venue-laboratories.jpg)
Cover Story
Free
It takes a few clicks to look up the name of a company that holds the “Abbreviated New Drug Application,” or ANDA, to make a generic drug. Alas, this information is of little value.
In Brief
Trending Stories
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- Proposed rule by CMS would expand access to cancer treatment at tribal facilities
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence